21 completed, 17 recruiting, 14 unknown, 10 active not recruiting. 75 Phase 2, 15 Phase 3, 12 Phase 1.
Follow Standard therapy: new trials by email Literature Review of Standard therapy trials Research Report on Standard therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Home-Based Outpatient Model for BCG Delivery to Reduce Undue Burden on Patients Undergoing Treatment for Non-Muscle Invasive Bladder Carcinoma BCG Solution, Best Practice, Cystoscopy - Non-Muscle Invasive Bladder Carcinoma | Phase 1 / Phase 2 | Not yet recruiting | Ohio State University Comprehensive Cancer Center | 49 | 2027-01-15 | 2026-10-14 |
| Cannabis Gummy for the Improvement of Sleep and Quality of Life in Patients With Cancer, Pillow Trial Actigraphy, Best Practice, Biospecimen Collection - Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | Phase 1 / Phase 2 | Not yet recruiting | Theodore Brasky PhD | 50 | 2027-01-15 | 2026-10-14 |
| Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis Telitacicept 160mg, Standard therapy - Difficult-to-treat Rheumatoid Arthritis, Rheumatoid Arthritis | Phase 2 | Recruiting | Peking University People's Hospital | 420 | 2026-09-01 | 2026-09-01 |
| [18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer Best Practice, Biopsy of Breast, Computed Tomography - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma | Phase 1 / Phase 2 | Recruiting | University of Washington | 22 | 2026-02-26 | 2026-05-19 |
| Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial Best Practice, Olanzapine, Questionnaire Administration - Cancer-Associated Anorexia, Head and Neck Squamous Cell Carcinoma | Phase 2 | Recruiting | Roswell Park Cancer Institute | 66 | 2025-12-24 | 2026-08-18 |
| Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease Standard Therapy, Erdosteine - Fatty Liver | Phase 1 / Phase 2 | Recruiting | Tanta University | 50 | 2025-11-20 | 2025-12-10 |
| SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome Dapagliflozin, Empagliflozin, Standard Therapy - Nephrotic Syndrome | Phase 2 / Phase 3 | Recruiting | Mansoura University | 75 | 2025-11-15 | 2026-06-09 |
| Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease Standard therapy, Cilostazol - Fatty Liver | Phase 1 / Phase 2 | Recruiting | Tanta University | 50 | 2025-11-01 | 2025-11-25 |
| Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity Standard of Care Chemotherapy, Biospecimen Collection, Computed Tomography - Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 2 / Phase 3 | Recruiting | ECOG-ACRIN Cancer Research Group | 148 | 2025-10-24 | 2026-10-05 |
| A Prospective Study of Madecassoside Tablets in Sclerotic Chronic Graft-versus-Host Disease After Allo-HSCT Madecassoside Tablets, Standard Therapy - Chronic Graft-Versus-Host Disease, Graft vs Host Disease | Phase 2 | Recruiting | WeiShi | 30 | 2025-09-01 | 2026-05-26 |
| Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers Best Practice, Biospecimen Collection, Central Venous Cannula Insertion - Metastatic Bladder Urothelial Carcinoma, Metastatic Renal Pelvis and Ureter Urothelial Carcinoma | Phase 2 | Recruiting | Mayo Clinic | 70 | 2025-08-01 | 2026-05-08 |
| Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer Best Practice, Biospecimen Collection, Cisplatin - Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 2 | Recruiting | NRG Oncology | 98 | 2025-06-23 | 2026-08-17 |
| The Relationship Between Microbioma Balance and Acne Vulgaris as a New Acne Treatment Standard therapy, HEXBIO, Secretome - Acne Vulgaris | Phase 2 | Not yet recruiting | Universitas Padjadjaran | 64 | 2025-05-01 | 2025-04-13 |
| Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers Best Practice, Cilostazol, Cryocompression Therapy - Cervical Carcinoma, Fallopian Tube Carcinoma | Phase 2 | Recruiting | Emory University | 70 | 2024-08-01 | 2026-08-27 |
| MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies Trametinib tablet, Standard therapy - Cardiomegaly, Noonan Syndrome | Phase 2 | Recruiting | Medical University of Warsaw | 40 | 2024-08-01 | 2024-08-15 |
| Clinical Outcome of Vinpocetine in Diabetic Nephropathy Vinpocetine, Standard Therapy, Placebo - Diabetic Kidney Disease, Diabetic Nephropathies | Phase 2 / Phase 3 | Unknown | Ain Shams University | 64 | 2024-07-10 | 2024-07-11 |
| MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) Allogeneic Hematopoietic Stem Cell Transplantation, Azacitidine, Best Practice - Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm | Phase 2 | Recruiting | National Cancer Institute (NCI) | 2000 | 2024-06-18 | 2026-10-29 |
| Remote Cognitive Assessment and Wearable Device While Assessing the Impact of Metformin in Patients With History of Cranial Radiation Therapy Best Practice, Medical Device Usage and Evaluation, Metformin - Malignant Brain Neoplasm | Phase 2 | Active not recruiting | Mayo Clinic | 100 | 2024-05-31 | 2026-10-02 |
| Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study Best Practice, Cognitive Intervention, Comprehensive Geriatric Assessment - B-Cell Non-Hodgkin Lymphoma, Multiple Myeloma | Phase 2 | Recruiting | City of Hope Medical Center | 164 | 2023-06-23 | 2026-10-22 |
| Neuropsychological Care for Maintaining Quality of Life After Radiation Therapy in Patients With Brain Metastases Best Practice, Neuropsychological Assessment, Quality-of-Life Assessment - Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm | Phase 2 | Completed | Ohio State University Comprehensive Cancer Center | 110 | 2022-08-30 | 2026-10-21 |
Showing 20 of 75. Sign in to see all of them.
COVID-19 (6) · Breast Neoplasms (3) · Cerebral Palsy (3) · Diabetic Foot (3) · Diabetic Neuropathies (3) · Hematologic Neoplasms (3) · Leukemia, Myeloid, Acute (3) · Neoplasms (3) · Shock, Septic (3) · Brain Neoplasms (2) · Chronic Limb-Threatening Ischemia (2) · Coronavirus Infections (2) · Fatty Liver (2) · Glioblastoma (2) · Mouth Neoplasms (2)
M.D. Anderson Cancer Center (11) · Mayo Clinic (4) · Duta Wacana Christian University (3) · City of Hope Medical Center (2) · Englewood Hospital and Medical Center (2) · Fred Hutchinson Cancer Center (2) · Mansoura University (2) · Mario Negri Institute for Pharmacological Research (2) · Novo Nordisk A/S (2) · Ohio State University Comprehensive Cancer Center (2) · Roswell Park Cancer Institute (2) · State-Financed Health Facility "Samara Regional Medical Center Dinasty" (2) · Tanta University (2) · University of Catanzaro (2) · Ain Shams University (1)
United States (37) · Indonesia (6) · Egypt (5) · Italy (5) · China (4) · Germany (4) · Russia (4) · Spain (3) · Australia (2) · Canada (2) · France (2) · India (2) · Norway (2) · Poland (2) · United Kingdom (2)
Kurt Wengerter, MD (2) · Rizaldy T Pinzon, MD, MSc, PhD (2) · Amanda Olson (1) · Amin M Alousi (1) · Amr Ahmed (1) · Anders Erik Astrup Dahm, MD, PHD (1) · Andrew S Artz (1) · Andrew W Gorlin, M.D. (1) · Anna Lee (1) · Anurag K Singh (1) · Carlos Roldan (1) · Carme Casajuana, PT (1) · Chad Tang (1)
PMID 16102099, PMID 16947627, PMID 21796368, PMID 22198468, PMID 22623692, PMID 22649152, PMID 23817721, PMID 25030060, PMID 25913905, PMID 26618098, PMID 27406346, PMID 27406347, PMID 28851423, PMID 29801515, PMID 29867923, PMID 30251913, PMID 30679183, PMID 32031889, PMID 32053137, PMID 32129478, PMID 32450725, PMID 32691060, PMID 32701140, PMID 32871021, PMID 34529000, PMID 34658014, PMID 34741021, PMID 34984028, PMID 35226080, PMID 35330830, PMID 35623341, PMID 35761219, PMID 35993306, PMID 36069821, PMID 36324139, PMID 36456573, PMID 36902217, PMID 37022702, PMID 37029329, PMID 37043555, PMID 37325931, PMID 37505107, PMID 38086377, PMID 38129117, PMID 38180338, PMID 38745646, PMID 39102622, PMID 39158353, PMID 39235623, PMID 39277671
P30CA016672 (2), P30CA033572 (2), 2008 (1), P30CA015704 (1), P30CA072720 (1), P30CA138292 (1), R01CA222382 (1), R01CA227092 (1), R21CA236057 (1), U10CA180820 (1), U10CA180888 (1), UG1CA189867 (1), UG1CA189974 (1)